← Leaderboards
Yi Ye
New York University
$8,884,555
Attributed
$14,157,587
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2018–25$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,157,587 · 5
By mechanism
R01$9,019,976 · 3
RM1$4,820,611 · 1
R03$317,000 · 1
Top collaborators
- Nigel W Bunnett1 shared
- Wendy Marie Campana1 shared
- Rajesh Khanna1 shared
- Kam W Leong1 shared
- Brian L Schmidt1 shared
Most similar at New York University
Same institution · by research overlap
- Brian L Schmidt$17,732,867
- Markus Hardt$1,927,957
- Vivian Santiago$823,230
- Aditi Bhattacharya$989,660
- Nigel W Bunnett$19,331,815
Others in their field
Other Emerging Leaders on “Pain”
- Abraham Aizer Brody · New York University School Of Medicine$25,530,786
- Jeffrey Reich · Sparian Biosciences, Inc.$21,671,295
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Barbara Burtness · Yale University$11,235,253
- William Russell Renthal · Brigham And Women'S Hospital$11,023,625
Research focus
PainNeuronsNociceptionCancer PatientCellsMalignant Mouth NeoplasmMalignant NeoplasmsQuality Of LifeTumorPain ManagementCancer PainNociceptorsBehaviorMediatingClinical TrialsResponseSchwann CellsReceptorCell TypeNervePeripheralOverexpressionPeripheral NervesMalignant Neoplasm Of Pancreas
Grant awards (11)
Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance$1,561,072
R01 · FY2025 · DE · contact PI
Targeting Schwann cell dysfunction and repair signaling in chemotherapy induced painful peripheral neuropathy$2,833,086
R01 · FY2024 · DE · contact PI
Schwann cell activation in oral cancer perineurial invasion and neuropathic pain$371,008
R01 · FY2024 · DE · contact PI
Endosomal mechanisms signaling oral cancer pain$4,820,611
RM1 · FY2023 · DE
Schwann cell activation in oral cancer perineurial invasion and neuropathic pain$378,579
R01 · FY2023 · DE · contact PI
Targeting HB-EGF and trigeminal EGFR for oral cancer pain and opioid tolerance$2,389,676
R01 · FY2022 · DE · contact PI
Schwann cell activation in oral cancer perineurial invasion and neuropathic pain$476,352
R01 · FY2022 · DE · contact PI
Schwann cell activation in oral cancer perineurial invasion and neuropathic pain$488,133
R01 · FY2021 · DE · contact PI
Schwann cell activation in oral cancer perineurial invasion and neuropathic pain$522,070
R01 · FY2020 · DE · contact PI
Schwann Cell Activation and Oral Cancer Pain$158,500
R03 · FY2019 · DE · contact PI
Schwann Cell Activation and Oral Cancer Pain$158,500
R03 · FY2018 · DE · contact PI